RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Orphazyme A/S Stock

Orphazyme A/S Employees 2024

Orphazyme A/S Employees

141

Ticker

ORPHA.CO

ISIN

DK0060910917

WKN

A2H7EV

In 2024, Orphazyme A/S employed 141 people, a 0% change from the 141 number of employees in the previous year.

Orphazyme A/S Aktienanalyse

What does Orphazyme A/S do?

Orphazyme A/S is a Danish biopharmaceutical company specializing in the development of therapies for rare neurodegenerative diseases. They focus on researching amyloids, insoluble protein complexes found in various neurodegenerative diseases. Their business model involves developing and marketing therapeutic treatments for these rare neurodegenerative diseases. They specialize in four disease areas: Niemann-Pick disease type C (NPC), Gaucher disease, sporadic inclusion body myositis (sIBM), and amyotrophic lateral sclerosis (ALS). They concentrate on developing drugs that control lysosomal function and the breakdown of biocatalysts. Their advanced product, Arimoclomol, is currently being tested in a Phase 3 trial for the treatment of NPC disease. Orphazyme has collaborations with other companies and research institutions to advance their research and development efforts. These include a partnership with Sobi for the exclusive rights to market Arimoclomol in Europe and a collaboration with QIAGEN to develop biomarkers for diagnosing NPC disease. Overall, Orphazyme is a promising company focused on providing much-needed solutions for rare neurodegenerative diseases through their pipeline of therapies. They are well-positioned to become a leading player in the biopharmaceutical industry in the future. Orphazyme A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Orphazyme A/S's Employee Base

Orphazyme A/S's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Orphazyme A/S's operational capacity and future potential.

Year-to-Year Comparison

Assessing Orphazyme A/S's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Orphazyme A/S's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Orphazyme A/S’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Orphazyme A/S stock

How many employees does Orphazyme A/S have this year?

Orphazyme A/S has 141 undefined employees this year.

How many employees did Orphazyme A/S have compared to the previous year?

Compared to the previous year, Orphazyme A/S had 0% more employees.

What impact did the number of employees have on the company Orphazyme A/S?

The number of employees has a direct impact on the efficiency and productivity of Orphazyme A/S. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Orphazyme A/S?

The number of employees can also have an impact on investors of Orphazyme A/S, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Orphazyme A/S affect the company?

An increase in equity of Orphazyme A/S can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Orphazyme A/S's equity affect the company?

A reduction in equity of Orphazyme A/S can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Orphazyme A/S?

Some factors that can influence the equity of Orphazyme A/S include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Orphazyme A/S so important for investors?

The equity of Orphazyme A/S is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Orphazyme A/S influence the company?

The number of employees at Orphazyme A/S can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Orphazyme A/S evolved in recent years?

In recent years, the number of employees at Orphazyme A/S has changed by 0.

How many employees does Orphazyme A/S currently have?

Orphazyme A/S currently has 141 undefined employees.

Why is the number of employees important for investors of Orphazyme A/S?

The number of employees is important for investors of Orphazyme A/S as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Orphazyme A/S take to change the number of employees?

To change the number of employees, Orphazyme A/S can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Orphazyme A/S pay?

Over the past 12 months, Orphazyme A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orphazyme A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of Orphazyme A/S?

The current dividend yield of Orphazyme A/S is .

When does Orphazyme A/S pay dividends?

Orphazyme A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Orphazyme A/S?

Orphazyme A/S paid dividends every year for the past 0 years.

What is the dividend of Orphazyme A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Orphazyme A/S located?

Orphazyme A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Orphazyme A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Orphazyme A/S from 9/20/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Orphazyme A/S pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Orphazyme A/S in the year 2023?

In the year 2023, Orphazyme A/S distributed 0 DKK as dividends.

In which currency does Orphazyme A/S pay out the dividend?

The dividends of Orphazyme A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Orphazyme A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Orphazyme A/S

Our stock analysis for Orphazyme A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orphazyme A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.